Skip to content

Company information lookup

OSPREY MEDICAL INC (OSP)

Development and commercialization of its proprietary AVERT Plus System, a medical device used for the prevention of Contrast Induced Nephropathy (CIN).

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
OSP 0.550 0% 0.555 0.570 0.000 0.000 0.000 0

OSPREY MEDICAL INC details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code OSP
Securities
Official Listing Date 2 May, 2012
GICS Industry Group Health Care Equipment & Services
Exempt Foreign? No
Internet Address http://www.ospreymed.com
Registered Office Address Level 13, 41 Exhibition Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone 0410 442 393
Head Office Fax (03) 9663 6609
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 1, 333 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr John Erb (Chairman)
Mr Mike McCormick (Managing Director)
Mr Andy Jane (Director)
Mr Neville Mitchell (Director)
Dr Chris Nave (Director)
Company Secretary Mr Brendan Case
Principal Activities Development and commercialization of its proprietary AVERT Plus System, a medical device used for the prevention of Contrast Induced Nephropathy (CIN).

OSPREY MEDICAL INC announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
20/10/2014 asterix Appendix 4C - quarterly 7 PDF
18/09/2014   CEO Investor Presentation - 18 September 2014 16 PDF
15/09/2014   AVERT to be presented at leading Cardiovascular Conference 3 PDF
22/08/2014 asterix Half Yearly Report and Accounts 21 PDF
04/08/2014   CEO Presentation August 2014 27 PDF
04/08/2014   Investor Newsletter August 2014 4 PDF
04/08/2014 asterix Physicians use AVERT in peripheral artery disease procedures 2 PDF
22/07/2014 asterix Appendix 4C - quarterly 7 PDF
17/06/2014 asterix US FDA Clearance for the AVERT System 2 PDF
20/05/2014   Appendix 3Y 3 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Oct 2014 0.550 -5.17% 0.550 0.550 31,400
20 Oct 2014 0.580 5.45% 0.580 0.530 10,603
15 Oct 2014 0.550 -5.17% 0.550 0.550 6,500
13 Oct 2014 0.580 0% 0.580 0.580 22,931
10 Oct 2014 0.580 0% 0.580 0.580 308,735

* Volume of shares shown represents only those shares traded on ASX.

OSPREY MEDICAL INC price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security OSP. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security OSP

Warrants & Structured Products

No warrants & Structured Products are available over the security OSP